235 related articles for article (PubMed ID: 12351594)
1. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration.
Smaletz O; Scher HI; Small EJ; Verbel DA; McMillan A; Regan K; Kelly WK; Kattan MW
J Clin Oncol; 2002 Oct; 20(19):3972-82. PubMed ID: 12351594
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A
Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216
[TBL] [Abstract][Full Text] [Related]
3. A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis.
Armstrong AJ; Garrett-Mayer ES; Yang YC; de Wit R; Tannock IF; Eisenberger M
Clin Cancer Res; 2007 Nov; 13(21):6396-403. PubMed ID: 17975152
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.
Kelly WK; Scher HI; Mazumdar M; Vlamis V; Schwartz M; Fossa SD
J Clin Oncol; 1993 Apr; 11(4):607-15. PubMed ID: 7683043
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis and development of a prognostic nomogram for bone-metastatic prostate cancer patients: A single-center experience in Indonesia.
Afriansyah A; Hamid ARA; Mochtar CA; Umbas R
Int J Urol; 2019 Jan; 26(1):83-89. PubMed ID: 30269369
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
7. Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer.
Armstrong AJ; Garrett-Mayer E; de Wit R; Tannock I; Eisenberger M
Clin Cancer Res; 2010 Jan; 16(1):203-11. PubMed ID: 20008841
[TBL] [Abstract][Full Text] [Related]
8. Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer.
Miyoshi Y; Noguchi K; Yanagisawa M; Taguri M; Morita S; Ikeda I; Fujinami K; Miura T; Kobayashi K; Uemura H
BMC Cancer; 2015 May; 15():338. PubMed ID: 25929438
[TBL] [Abstract][Full Text] [Related]
9. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Kattan MW; Shariat SF; Andrews B; Zhu K; Canto E; Matsumoto K; Muramoto M; Scardino PT; Ohori M; Wheeler TM; Slawin KM
J Clin Oncol; 2003 Oct; 21(19):3573-9. PubMed ID: 12913106
[TBL] [Abstract][Full Text] [Related]
10. A Novel Nomogram for Survival Prediction of Patients with Spinal Metastasis From Prostate Cancer.
Liu Y; Li L; Jiang D; Yang M; Gao X; Lv K; Xu W; Wei H; Wan W; Xiao J
Spine (Phila Pa 1976); 2021 Mar; 46(6):E364-E373. PubMed ID: 33620180
[TBL] [Abstract][Full Text] [Related]
11. Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy.
Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Pond G; Godbold J; Oh WK; Bamias A
Urol Oncol; 2014 Jan; 32(1):48.e1-8. PubMed ID: 24055428
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.
Kattan MW; Zelefsky MJ; Kupelian PA; Cho D; Scardino PT; Fuks Z; Leibel SA
J Clin Oncol; 2003 Dec; 21(24):4568-71. PubMed ID: 14673043
[TBL] [Abstract][Full Text] [Related]
13. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Stephenson AJ; Scardino PT; Eastham JA; Bianco FJ; Dotan ZA; DiBlasio CJ; Reuther A; Klein EA; Kattan MW
J Clin Oncol; 2005 Oct; 23(28):7005-12. PubMed ID: 16192588
[TBL] [Abstract][Full Text] [Related]
14. External validation and newly development of a nomogram to predict overall survival of abiraterone-treated, castration-resistant patients with metastatic prostate cancer.
Yang YJ; Lin GW; Li GX; Dai B; Ye DW; Wu JL; Xie HY; Zhu Y
Asian J Androl; 2018; 20(2):184-188. PubMed ID: 29111539
[TBL] [Abstract][Full Text] [Related]
15. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Graefen M; Karakiewicz PI; Cagiannos I; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Klein E; Kupelian P; Skinner DG; Lieskovsky G; Bochner B; Huland H; Hammerer PG; Haese A; Erbersdobler A; Eastham JA; de Kernion J; Cangiano T; Schröder FH; Wildhagen MF; van der Kwast TH; Scardino PT; Kattan MW
J Clin Oncol; 2002 Aug; 20(15):3206-12. PubMed ID: 12149292
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the predictive accuracy and the clinical benefit of a nomogram aimed to predict survival in node-positive prostate cancer patients: External validation on a multi-institutional database.
Bianchi L; Schiavina R; Borghesi M; Bianchi FM; Briganti A; Carini M; Terrone C; Mottrie A; Gacci M; Gontero P; Imbimbo C; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Novara G; Porreca A; Volpe A; Brunocilla E
Int J Urol; 2018 Jun; 25(6):574-581. PubMed ID: 29633372
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.
Scher HI; Jia X; de Bono JS; Fleisher M; Pienta KJ; Raghavan D; Heller G
Lancet Oncol; 2009 Mar; 10(3):233-9. PubMed ID: 19213602
[TBL] [Abstract][Full Text] [Related]
18. A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate.
Elshafei A; Kovac E; Dhar N; Levy D; Polascik T; Mouraviev V; Yu C; Jones JS
Prostate; 2015 Sep; 75(13):1447-53. PubMed ID: 26172607
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.
Kattan MW; Zelefsky MJ; Kupelian PA; Scardino PT; Fuks Z; Leibel SA
J Clin Oncol; 2000 Oct; 18(19):3352-9. PubMed ID: 11013275
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a prognostic nomogram for terminally ill cancer patients.
Feliu J; Jiménez-Gordo AM; Madero R; Rodríguez-Aizcorbe JR; Espinosa E; Castro J; Acedo JD; Martínez B; Alonso-Babarro A; Molina R; Cámara JC; García-Paredes ML; González-Barón M
J Natl Cancer Inst; 2011 Nov; 103(21):1613-20. PubMed ID: 21972226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
